We next evaluated whether the effects of CIGB-300 on viability and proliferation of T-ALL cells could be counteracted by IL-7-mediated signals, which are known to prevent apoptosis and promote T-ALL growth in vitro and in vivo [26]. This evidence concerns the gene IL7 and acute lymphoblastic leukemia.